Are you Dr. Macapinlac?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 71 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Summary
- Dr. Homer Macapinlac, MD is a board certified nuclear medicine physician in Houston, Texas. He is currently licensed to practice medicine in Texas and New York. He is affiliated with University of Texas M.D. Anderson Cancer Center.
Education & Training
- Memorial Sloan Kettering Cancer CenterResidency, Nuclear Medicine, 1989 - 1994
- New York Medical College at St Vincent's Hospital and Medical Center of New YorkResidency, Pathology-Anatomic and Clinical, 1987 - 1989
- University of the East College of MedicineClass of 1983
Certifications & Licensure
- TX State Medical License 2002 - 2025
- NY State Medical License 1994 - 2021
- American Board of Nuclear Medicine Nuclear Medicine
Clinical Trials
- F18PET/CT Versus TC-MDP Scanning to Detect Bone Mets Start of enrollment: 2009 Jan 01
Publications & Presentations
PubMed
- Assessing the Effectiveness of Selective RET Inhibitors in RET-Positive Cancers through Fluorodeoxyglucose Uptake Analysis.Kalevi Kairemo, Homer A Macapinlac, Mohammed Gouda, Vivek Subbiah
Diagnostics. 2024-08-28 - 1 citationsDeciphering Tumor Response: The Role of Fluoro-18-d-Glucose Uptake in Evaluating Targeted Therapies with Tyrosine Kinase Inhibitors.Kalevi Kairemo, Mohamed Gouda, Hubert H Chuang, Homer A Macapinlac, Vivek Subbiah
Journal of Clinical Medicine. 2024-05-31 - 74 citationsSafety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19B cell tumors: a phase 1/2 trial.David Marin, Ye Li, Rafet Basar, Hind Rafei, May Daher
Nature Medicine. 2024-03-01